Lakefront Biotherapeutics NV 2021 Annual Report with Sustainability Disclosures
Company: Lakefront Biotherapeutics NV
Sector: Professional & technical services
Country: Belgium
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 284
The report describes 2021 as a year of commercial transition, with Galapagos becoming marketing authorization holder for Jyseleca in Europe and reporting €14.8 million in product net sales. It highlights a refocused R&D portfolio, including 49 preclinical candidates generated since 2009 and 24 entering the clinic. The company reported 1,309 group employees and a supervisory board with four women among eight members. Its CSR report organizes sustainability around four material aspects and reports no work-related fatalities.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.